NAFLD, NASH and liver cancer

@article{Michelotti2013NAFLDNA,
  title={NAFLD, NASH and liver cancer},
  author={Gregory A Michelotti and Mariana Verdelho Machado and Anna Mae Diehl},
  journal={Nature Reviews Gastroenterology \&Hepatology},
  year={2013},
  volume={10},
  pages={656-665}
}
NAFLD affects a large proportion of the US population and its incidence and prevalence are increasing to epidemic proportions around the world. As with other liver diseases that cause cirrhosis, NAFLD increases the risk of liver cancer, a disease with poor outcomes and limited therapeutic options. The incidences of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma are also rising, and HCC is now the leading cause of obesity-related cancer deaths in middle-aged men in the USA… Expand
Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC.
TLDR
The global NAFLD epidemic has arrived at the doorstep and demands the attention, especially when compared to cardiovascular disease and extrahepatic malignancies. Expand
NON-ALCOHOLIC FATTY LIVER DISEASE - CHANGING THE PREVALENCE OF LIVER CANCER?
TLDR
The epidemiology, aetiology, and pathogenesis of HCC on the background of NAFLD are reviewed and potential consequences for the management of patients in respect to theNAFLD epidemic are deduced. Expand
Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes
TLDR
Recent findings of both ‘intrinsic’ effects on hepatocytes and the role of the local environment in NAFLD‐promoted HCC development are explored. Expand
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
TLDR
A deeper understanding of the mechanisms mediating hepatic carcinogenesis during insulin resistance, and the identification of its genetic determinants will hopefully provide new diagnostic and therapeutic tools. Expand
NAFLD: a multisystem disease.
TLDR
A narrative review focuses on the rapidly expanding body of clinical evidence that supports the concept of NAFLD as a multisystem disease and the factors linkingNAFLD with other extra-hepatic chronic diseases, such as T2DM, CVD, cardiac diseases and CKD. Expand
Update in global trends and aetiology of hepatocellular carcinoma
TLDR
This is a narrative review of findings of multiple studies that were retrieved from electronic databases like PubMed, MEDLINE, Embase, Google Scholar, Scopus, and Cochrane about the epidemiology and various risk factors for the development of HCC. Expand
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.
TLDR
The epidemiology, risk factors, features, and prevention of NAFLD-associated HCC are summarized and aggressive treatment should be pursued in appropriate patients. Expand
A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
TLDR
The long-term prognosis after curative surgery for MS-related HCC does not seem to be worse than for other HCC occurring on classical chronic liver diseases, and several medical therapies including metformin could be of value in the prevention of both occurrence and recurrence of HCC. Expand
Obesity and Hepatocarcinogenesis
Obesity has been recognized as a cluster of risk factors associated with type 2 diabetes (T2D), cardiovascular morbidity, and higher frequency of cancers in a variety of tissues including the liver.Expand
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
TLDR
Although standardization procedures and larger, independent studies are still necessary, miRNAs constitute promising, clinically-useful biomarkers for the NAFLD-HCC spectrum. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 151 REFERENCES
Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
TLDR
NAFLD/NASH as the hepatic entity of the MS may itself pose a risk factor for HCC, even in the absence of cirrhosis, and increased awareness of liver manifestations in theMS may instigate early interventions against developing HCC. Expand
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.
TLDR
Hepatitis C and cryptogenic liver disease are the most common etiologies of diseases in patients with HCC, and NAFLD accounted for at least 13% of the cases. Expand
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
TLDR
Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disease in the United States, and steatosis alone has a more benign clinical course, although progression to cirrhosis has occurred in 3% of these patients. Expand
Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.
TLDR
Regular surveillance in patients with NAFLD for HCC is necessary, especially for elderly men with metabolic syndrome, as patients withNAFLD-associated HCC are usually accompanied with metabolic disorders. Expand
Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?
TLDR
The cases presented here suggest that NAFLD may predispose patients to HCC in the absence of cirrhosis, and further studies are needed to confirm this potentially important observation. Expand
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
TLDR
Patients with HCC in the setting of NASH have less severe liver dysfunction at HCC diagnosis and better OS after curative treatment compared to counterparts with HCV and/or alcoholic liver disease. Expand
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
TLDR
In conclusion, more frequent surveillance for HCC may be warranted in obese patients with alcoholic and cryptogenic cirrhosis, as this study is based on patients with advanced Cirrhosis and findings need to be confirmed in a broader population of individuals with cirrhotic disease. Expand
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
TLDR
Modest intake of alcohol might have a more significant role in hepatic carcinogenesis than is presently thought in Japanese patients with non-viral liver disease. Expand
Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C.
TLDR
It is demonstrated that age, hepatic fibrosis, and hepatic steatosis at pre-interferon treatment might be risk factors for developing HCC after SVR. Expand
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction
TLDR
PNPLA3 genetic variation may determine individual susceptibility to HCC development and poor prognosis, and further experimental investigations are necessary for thorough assessment of the hepatocarcinogenic role of PN PLA3. Expand
...
1
2
3
4
5
...